Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine-Russia War
4.3 Impact of Ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Anticoagulation Market Segmentation, By Drug Class
8.1 Direct Oral Anticoagulants (DOACS)
8.2 Warfarin
8.3 Other Vitamin K
8.4 Low Molecular Weight Heparin (LMWH)
9. Anticoagulation Market Segmentation, By Disease Indication
9.1 Heart Attack
9.2 Stroke
9.3 Deep Vein Thrombosis/ Pulmonary Embolism DVT/PE
9.4 Mechanical Heart Valves (MHV)
10. Anticoagulation Market Segmentation, By Route of Administration (ROA)
10.1 Oral
10.2 Injectable
10.3 Others
11. Anticoagulation Market Segmentation, By Distribution Channel
11.1 Retail Pharmacy
11.2 Hospital Pharmacies
11.3 Online Pharmacies
12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 USA
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 France
12.3.4 Italy
12.3.5 Spain
12.3.6 The Netherlands
12.3.7 Rest of Europe
12.4 Asia-Pacific
12.4.1 Japan
12.4.2 South Korea
12.4.3 China
12.4.4 India
12.4.5 Australia
12.4.6 Rest of Asia-Pacific
12.5 The Middle East & Africa
12.5.1 Israel
12.5.2 UAE
12.5.3 South Africa
12.5.4 Rest
12.6 Latin America
12.6.1 Brazil
12.6.2 Argentina
12.6.3 Rest of Latin America
13. Company Profiles
13.1 Bristol-Myers Squibb Company
13.1.1 Financial
13.1.2 Products/ Services Offered
13.1.3 SWOT Analysis
13.1.4 The SNS view
13.2 Pfizer Inc
13.3 Daiichi Sankyo Company
13.4 Limited
13.5 Hoffmann-La Roche Ltd
13.6 Johnson & Johnson Services Inc
13.7 GlaxoSmithKline plc
13.8 Boehringer Ingelheim International GmbH
13.9 Portola Pharmaceuticals, Inc
13.10 Novartis AG, Sanofi
14. Competitive Landscape
14.1 Competitive Benchmark
14.2 Market Share Analysis
14.3 Recent Developments
15. Conclusion
